TIFFANY SLAUGHTER: Open Payments
NPI 1558991513 · PINEVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$768 in 38 payments from 9 companies in 2025. Trend: 2023 $842 · 2024 $820 · 2025 $768
Food & beverage: $768
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 13 | $270 |
| ABBVIE INC. | 12 | $232 |
| Endo USA, Inc. | 3 | $48 |
| Dendreon Pharmaceuticals LLC | 2 | $48 |
| TOLMAR, INC. | 2 | $47 |
| ACCORD HEALTHCARE, INC. | 2 | $40 |
| Ferring Pharmaceuticals Inc. | 2 | $37 |
| 180 Medical, Inc. | 1 | $25 |
| Blue Earth Diagnostics | 1 | $22 |
Products named: GEMTESA, BOTOX, LUPRON DEPOT, XIAFLEX, PROVENGE, ELIGARD, Camcevi, ADSTILADRIN.
Industry payments across LA — which companies pay providers there.
